New hope for kids with tough cancer: Two-Year pill aims to keep neuroblastoma away
Disease control
Ongoing
This study is testing whether taking the drug eflornithine for two years can help keep cancer from coming back in children with high-risk neuroblastoma who have already finished their main treatments, including immunotherapy. Researchers will follow 20 children under 18 to see if…
Sponsor: Shanghai Children's Hospital • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC